A detailed history of Neos Investment Management LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 24,481 shares of ARCT stock, worth $378,965. This represents 0.02% of its overall portfolio holdings.

Number of Shares
24,481
Previous 22,600 8.32%
Holding current value
$378,965
Previous $550 Million 3.25%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.08 - $25.38 $34,008 - $47,739
1,881 Added 8.32%
24,481 $568 Million
Q2 2024

Aug 14, 2024

BUY
$24.35 - $44.39 $119,315 - $217,511
4,900 Added 27.68%
22,600 $550 Million
Q1 2024

May 13, 2024

BUY
$31.23 - $42.99 $282,225 - $388,500
9,037 Added 104.32%
17,700 $598 Million
Q4 2023

Feb 13, 2024

BUY
$17.71 - $32.97 $153,421 - $285,619
8,663 New
8,663 $273 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $411M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.